4D pharma plc Operating Income
4D pharma plc reported Operating Income of -$37.26 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-03-31
| Period end | Operating Income (Loss) 6 month | Operating Income (Loss) 12 month |
|---|---|---|
| 2021-12-31 | -$37.26M 20-F · filed 2022-03-31 | |
| 2021-06-30 | -$18.91M 6-K/A · filed 2022-02-18 | |
| 2020-12-31 | -$35.01M 20-F · filed 2022-03-31 | |
| 2020-06-30 | -$17.27M 6-K/A · filed 2022-02-18 | |
| 2019-12-31 | -$40.26M 20-F · filed 2022-03-31 | |
| 2018-12-31 | -$38.89M 20-F/A · filed 2021-04-30 |